BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36095314)

  • 21. External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality.
    Fortin Y; Crispo JA; Cohen D; McNair DS; Mattison DR; Krewski D
    PLoS One; 2017; 12(3):e0174379. PubMed ID: 28350807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptation and Validation of the Combined Comorbidity Score for ICD-10-CM.
    Sun JW; Rogers JR; Her Q; Welch EC; Panozzo CA; Toh S; Gagne JJ
    Med Care; 2017 Dec; 55(12):1046-1051. PubMed ID: 29087983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptation of the Acute Organ Failure Score for Use in a Medicare Population.
    Courtright KR; Halpern SD; Bayes B; Harhay MO; Raneses E; Kipnis P; Escobar GJ; Kerlin MP
    Crit Care Med; 2017 Nov; 45(11):1863-1870. PubMed ID: 28777196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke: the Elixhauser Index for comorbidity adjustment of in-hospital case fatality.
    Zhu H; Hill MD
    Neurology; 2008 Jul; 71(4):283-7. PubMed ID: 18645167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data.
    Southern DA; Quan H; Ghali WA
    Med Care; 2004 Apr; 42(4):355-60. PubMed ID: 15076812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of seven comorbidity scores on four-month survival of lung cancer patients.
    Pluchart H; Bailly S; Chanoine S; Moro-Sibilot D; Bedouch P; Toffart AC
    BMC Med Res Methodol; 2023 Nov; 23(1):256. PubMed ID: 37923993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival.
    Chang HJ; Chen PC; Yang CC; Su YC; Lee CC
    Medicine (Baltimore); 2016 Feb; 95(7):e2861. PubMed ID: 26886653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality.
    Chu YT; Ng YY; Wu SC
    BMC Health Serv Res; 2010 May; 10():140. PubMed ID: 20507593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comparison of the Charlson and Elixhauser Comorbidity Measures to Predict Inpatient Mortality After Proximal Humerus Fracture.
    Menendez ME; Ring D
    J Orthop Trauma; 2015 Nov; 29(11):488-93. PubMed ID: 26165266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general population.
    Stanley J; Sarfati D
    J Clin Epidemiol; 2017 Dec; 92():99-110. PubMed ID: 28844785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work.
    Austin SR; Wong YN; Uzzo RG; Beck JR; Egleston BL
    Med Care; 2015 Sep; 53(9):e65-72. PubMed ID: 23703645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Australian Injury Comorbidity Index to Predict Mortality.
    Fernando DT; Berecki-Gisolf J; Newstead S; Ansari Z
    Ann Emerg Med; 2020 Mar; 75(3):339-353. PubMed ID: 31955941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combined comorbidity score predicted mortality in elderly patients better than existing scores.
    Gagne JJ; Glynn RJ; Avorn J; Levin R; Schneeweiss S
    J Clin Epidemiol; 2011 Jul; 64(7):749-59. PubMed ID: 21208778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of 15-month mortality prediction models: a retrospective observational comparison of machine-learning techniques in a national sample of Medicare recipients.
    Berg GD; Gurley VF
    BMJ Open; 2019 Jul; 9(7):e022935. PubMed ID: 31315852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a 5-Year Mortality Prediction Model among U.S. Medicare Beneficiaries.
    Ross RK; Kuo TM; Webster-Clark M; Lewis CL; Kistler CE; Jonsson Funk M; Lund JL
    J Am Geriatr Soc; 2020 Dec; 68(12):2898-2902. PubMed ID: 32889756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elixhauser outperformed Charlson comorbidity index in prognostic value after ACS: insights from a national registry.
    Zhang F; Chiu Y; Ensor J; Mohamed MO; Peat G; Mamas MA
    J Clin Epidemiol; 2022 Jan; 141():26-35. PubMed ID: 34461210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity scores for administrative data benefited from adaptation to local coding and diagnostic practices.
    Bottle A; Aylin P
    J Clin Epidemiol; 2011 Dec; 64(12):1426-33. PubMed ID: 21764557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Composite Recipient Comorbidity and Demographic Index for Predicting In-Hospital Mortality in Heart Transplant Patients.
    Li R
    Exp Clin Transplant; 2023 Aug; 21(8):671-677. PubMed ID: 37698402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the Performance of Charlson and Elixhauser Comorbidity Indices to Predict In-Hospital Mortality Among a Chinese Population.
    Cai M; Liu E; Zhang R; Lin X; Rigdon SE; Qian Z; Belue R; Chang JJ
    Clin Epidemiol; 2020; 12():307-316. PubMed ID: 32256119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicare Claim-Based National Institutes of Health Stroke Scale to Predict 30-Day Mortality and Hospital Readmission.
    Kumar A; Roy I; Bosch PR; Fehnel CR; Garnica N; Cook J; Warren M; Karmarkar AM
    J Gen Intern Med; 2022 Aug; 37(11):2719-2726. PubMed ID: 34704206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.